Opioids Market Size to reach US$ 24.9 Billion by 2027 | Growth rate (CAGR of 3.3%)

According to IMARC Group’s latest report, the global opioids market to reach US$ 24.9 Billion by 2027, exhibiting at a CAGR of 3.3% during 2022-2027.

SHERIDAN, WYOMING, UNITED STATES, October 27, 2022 /EINPresswire.com/ -- According to IMARC Group’s latest report, titled “Opioids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global opioids market reached a value of US$ 20.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 24.9 Billion by 2027, exhibiting at a CAGR of 3.3% during 2022-2027.

This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Opioids refer to drugs utilized for controlling persistent and intense pain among patients who are suffering from chronic headaches and backaches. They can be categorized into numerous product types, such as codeine, fentanyl, methadone oxycodone, morphine, hydrocodone, etc., which can be administered into the vein via an intravenous (IV) injection or taken through oral and transdermal routes. These opioids interact with proteins in the brain, gut, spinal cord, and other parts of the body to obstruct pain signals and mask discomfort, thereby offering a sense of relief. Consequently, they are extensively used in hospitals, clinics, and other healthcare establishments across countries.

Request for a PDF sample of this report: https://www.imarcgroup.com/opioids-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Opioids Market Trends:

The elevating prevalence of cancer, on account of the excessive consumption of alcohol and tobacco, is among the key factors driving the opioids market. In addition to this, the expanding geriatric population and the increasing number of individuals undergoing surgical interventions across the globe are also positively influencing the market growth. Moreover, the growing participation of children in physical activities and professional sports that has led to an increase in the incidents of severe injuries and the shifting preferences toward effective painkillers that help reduce post-surgical pain, facilitate speedy recovery, and lower the chances of complications, including pneumonia and blood clots are acting as another significant growth-inducing factor. Apart from this, the inflating investments by various leading market players in research and development (R&D) activities to evaluate the efficacy and safety of the drugs in several new diseases are expected to bolster the opioids market over the forecasted period.

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Boehringer Ingelheim International GmbH
Hikma Pharmaceuticals PLC
Mallinckrodt plc
Pfizer Inc.
Purdue Pharma L.P.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Key Market Segmentation:

The report has categorized the market based on product type, application and distribution channel.

Breakup by Product Type:

Codeine 
Fentanyl
Methadone
Oxycodone
Morphine
Hydrocodone

Breakup by Application:

Pain Management
Cough Treatment
Diarrhea Treatment
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores
Others

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4559&flag=C

Key highlights of the report:                                                    

Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

Point-of-care Diagnostics Market: https://bit.ly/3swULM2

Negative Pressure Wound Therapy Market: https://bit.ly/3U2dN8M

Bioinformatics Market: https://bit.ly/3Fm04FK

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here